FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/03/083471 [Registered on: 26/03/2025] Trial Registered Prospectively
Last Modified On: 07/07/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Study to evaluate efficacy, safety, immunogenicity and pharmacokinetics of Lupin Nivolumab (LUBT022) with Innovator Nivolumab of Patients with locally advanced or metastatic non-small cell lung cancer 
Scientific Title of Study   A randomized, double-blind, multi-center, active-control, parallel group study to compare efficacy, safety, immunogenicity and pharmacokinetics of Lupin Nivolumab (LUBT022) with Innovator Nivolumab in patients with locally advanced or metastatic non-small cell lung cancer 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
LRP/ LUBT022/2024/002 version 1.1dated9 Dec 2024  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Chirag Shah 
Designation  Vice President  
Affiliation  Lupin Ltd  
Address  1st floor A Wing Green Building NDDD CRU Survey No 46A 47A Village Nande Tal Mulshi

Pune
MAHARASHTRA
412115
India 
Phone  02066749068  
Fax    
Email  chiragshah@lupin.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Chirag Shah 
Designation  Vice President  
Affiliation  Lupin Ltd  
Address  1st floor A Wing Green Building NDDD CRU Survey No 46A 47A Village Nande Tal Mulshi

Pune
MAHARASHTRA
412115
India 
Phone  02066749068  
Fax    
Email  chiragshah@lupin.com  
 
Details of Contact Person
Public Query
 
Name  Dr Neelam Kardekar  
Designation  Assistant Director  
Affiliation  Lupin Ltd  
Address  1st floor A Wing Green Building NDDD CRU Survey No 46A 47A Village Nande Tal Mulshi

Pune
MAHARASHTRA
412115
India 
Phone  02066747372  
Fax    
Email  neelamkardekar@lupin.com  
 
Source of Monetary or Material Support  
Lupin Limited, Lupin Research Park,46A/47A, Village Nande, Taluka Mulshi, Pune 412115, Maharashtra, India 
 
Primary Sponsor  
Name  Lupin Limited 
Address  Gate No: 1156, Village-Ghotawade, Taluka-Mulshi, Pune. Pin: 412115 Maharashtra, India 
Type of Sponsor  Pharmaceutical industry-Indian 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study
Modification(s)  
No of Sites = 59  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Dipti Rani Samantha  Acharya Harihar Postgraduate Institute of Cancer  PI chamber 4th floor Medical Oncology department room no 024 ground floor Cuttack Odisha India 753003
Cuttack
ORISSA 
9437032728

diptiranisamanta@rediffmail.com 
Dr Sandip Barik  AIIMS Bhubaneshwar  Ground Floor Dept of Radiation OPD Cubicle 1 Sijua Patrapada Bhubaneshwar Odisha India 751019
Cuttack
ORISSA 
9450381454

sandip.barik1@gmail.com 
Dr Ishu Gupta  Amerix Cancer Hospital  society of Unique Hospital and reserach institute sector 19, opp. welcome hotel Dwarka 110075 New Delhi
New Delhi
DELHI 
9899258492

ishuguptamd@gmail.com 
Dr K Pavithran  Amrita Institute of Medical Sciences  First floor A block Tower 1 AIMS Ponekkara PO Kochi 682041 Kerala
Ernakulam
KERALA 
9895367090

pavithrank@aims.amrita.edu 
Dr Prabagar Manickam  Ashwin Multispeciality Hospital  Sathy Road, 1, Alamu Nagar rd, Near GP Theatre, Gandhipuram, TamilNadu 641012 India
Coimbatore
TAMIL NADU 
9443681554

drprabagar.acr@gmail.com 
Dr Magesh Padmanabha Kamath   BGS Global Institute of Medical Sciences   Department of Medical Oncology BGS Global Institute of Medical Sciences No 67, BGS Health & Education City Uttarahalli Road Kengeri Bangalore 560060 Karnataka India
Bangalore
KARNATAKA 
9900587736

mangeshk.research@gmail.com 
Dr Tanmoy Mondal  Binayak Multi Speciality Hospital  Binayak Enclave 59 Kalicharan Ghosh Road West Bengal Kolkata 700050.
Kolkata
WEST BENGAL 
9051238499

tanmoy.nrs@gmail.com 
Dr Kuntal Ray  Charnock Hospital  Ground floor BMC 195 Biswa Bangla Sarani Teghoria Newtown Kolkata– 700157 India
Kolkata
WEST BENGAL 
9775281345

kuntal.1911@gmail.com 
Dr Kalyan Kusum Mukherjee  Chittaranjan National Cancer Institute  Room no. 303 3rd floor Research building Chittranjan National Cancer Institute 37 SP Mukherjee Road Kolkata West Bengal 700026 India
Kolkata
WEST BENGAL 
9830115905

kkmukherjee4u@hotmail.com 
Dr Akash Tiwari   DNS Hospital Pvt. Ltd   Basement 14 Anoop Nagar LIG Square AB Road Indore MP-452008
Indore
MADHYA PRADESH 
9968721696

akash07tiwari@gmail.com 
Dr Sanjay Rai  ESIC Medical College & Hospital  4th floor DAV College Road Near Saheed Bhagat Singh College New Industrial Township Faridabad Haryana 121001 India
Faridabad
HARYANA 
8766316202

drrai_s@yahoo.com 
Dr Rajat Bajaj  Fortis Hospital Noida  B-22, Sector 62, Noida- 201301, Uttar Pradesh, INDIA
Gautam Buddha Nagar
UTTAR PRADESH 
9953183797

rajatb.mamc@gmail.com 
Dr Shantanu Pendse  HCG Cancer Center  Ground floor Mouja Wanjri Khasra No 50 51 Ring Road Near Automotive Square Kalam Bande Nawaz Nagar Binaki Nagpur 440017 Maharashtra India
Nagpur
MAHARASHTRA 
8600863057

drshantanu.s@hcgel.com 
Dr Sanketh Kotne   HCG Cancer Centre  OPD-2 Ground floor plot no 10 survey no 13P APIIC Health City Arilova Chinnagadili Vishakhapatnam Andhrapradesh 530040
Visakhapatnam
ANDHRA PRADESH 
7013222831

drsanketh.k@hcgel.com 
Dr K Lakshmi Priyadarshini  HCG City Cancer Centre  Ground floor 33 25 33 CH Venkata krishnayya street Surya Rao Pet Vijayawada 520002 Andhra Pradesh India
Krishna
ANDHRA PRADESH 
996030988

priyadarshini006@gmail.com 
Dr Mukesh Chaudhari  HCG Manavata Cancer Center  Department of Medical Oncology first floor behind shivang auto Mumbai Naka-422004 Maharashtra India
Nashik
MAHARASHTRA 
9096920416

drmukesh@mcrinasik.com 
Dr Chirag Desai  Hemato Oncology Clinic Ahmedabad Pvt. Ltd.  Nirmaya Complex” Ground Floor to Third Floor, Beside Pandit Dindayal Upadhyay Auditorium, Rajpath Club Road, Off S G Highway,Ahmedabad-380054, Gujarat.
Ahmadabad
GUJARAT 
7600598812

chiragdesai.oncology@gmail.com 
Dr Alok Ranjan   Indira Gandhi Institute of Medical Science  1st floor Room No112 Sheikhpura Patna 800014 Bihar India
Patna
BIHAR 
8521861068

dralokranjansciigims@gmail.com 
Dr Vijay Bhargava  Jawaharlal Nehru Cancer Hospital and Research Centre  Idgah Hills PB No 32 Bhopal Madhya Pradesh 462001 India
Bhopal
MADHYA PRADESH 
9512965930

drvijayoncologist@gmail.com 
Dr Ameya Koranne  Kailash Cancer Hospital and Research Centre  Department of Medical Oncology Kailash Cancer Hospital and Research Centre Muni Seva Ashram Goraj Waghodia Vadodara 391760 Gujrat India
Vadodara
GUJARAT 
7874361520

ameya.koranne@gaeenash ram.org 
Dr Keshav Garg  Kainos Super Speciality Hospital  Kheri Sadh Bypass, Delhi road Rohatak, 124001, Haryana India
Rohtak
HARYANA 
9729179012

garg488keshav@gmail.com 
Dr Saurabh Prasad   KIMS-Kingsway Hospitals   Room number 501 5th floor KIMS Kingsway Hospitals Medisearch Lifesciences Pvt Ltd 44 Parwana Bhavan, Kingsway Road Kasturchand Park Nagpur440001 Maharashtra India
Nagpur
MAHARASHTRA 
7066580511

drsaurabhprasad@gmail.com 
Dr Priyanka Das   Kiran Multi Super Speciality Hospital and Research Center   Cluster-G OPD room no2 1st floor Near Sumul Dairy Surat 395004 Gujarat India
Surat
GUJARAT 
9987239416

drpriyankagdas@gmail.com 
Dr Rohan Bhise  KLEs Dr. Prabhakar Kore Hospital and Medical Research Centre  Cancer building Ground floor OPD number C3 NH Service Road Nehru Nagar Belagavi Karnataka 590010 India
Belgaum
KARNATAKA 
9448866712

rohanbhise30@gmail.com 
Dr Ashwin Rajbhoj  Life Point Multispecialty Hospital  No. 145, Sr, 1, Mumbai Pune Bypass Rd, Near Sayaji Hotel, Wakad, Pune, Maharashtra 411057
Pune
MAHARASHTRA 
8793398680

rajbhojashwin11@gmail.com 
Dr Poulami Basu   Lifeline Diagnostic Centre Cum Nursing Home  Department of oncology 4A Wood Street Kolkata- 700016 West Bengal India
Kolkata
WEST BENGAL 
6290073778

poulamibasu18386@gmail.com 
Dr Anuj Gupta  Mahamana Pandit Madan Mohan Malaviya Cancer Centre and Homi Bhabha Cancer Hospital  OPD 33 Ground floor D and T Block Madan Mohan Malaviya Cancer Centre MPMMM and Homi Bhabha Cancer Hospital (HBCH), Sundar Bagiya Near Nariya Gate BHU Campus Varanasi 221005 Uttar Pradesh India
Varanasi
UTTAR PRADESH 
9588229594

dr.anuj.gupta24@gmail.com 
DrRajanipriya Yedla  Mahatma Gandhi Cancer Centre  Vizag Plot No1 Sector7 MVP Colony Visakhapatnam Andhra Pradesh 530017
Visakhapatnam
ANDHRA PRADESH 
9640953911

drrajinipriya@gmail.com 
Dr Lalit Mohan Sharma   Mahatma Gandhi Medical College and Hospital  4th floor Clinical research room Sri Ram Cancer Centre SRCC annex building Sri Ram Cancer and Superspeciality Centre, Mahatma Gandhi Medical College and Hospital RIICO Institutional Area Tonk Road Sitapura Jaipur 302022
Jaipur
RAJASTHAN 
9928602244

drlalit2003@gmail.com 
Dr Saju S V   Meenakshi Mission Hospital & Research Centre  1st floor main building Lake Area Melur Road Madurai Tamil Nadu 625107
Madurai
TAMIL NADU 
7904423513

drsajusr@gmail.com 
Dr Ketan Shirsath  MGM Medical College and Hospital  Gate No 2 MGM Campus n 6 CIDCO Chhatrapati Sambhajinagar Aurangabad Maharashtra 431003 Basement room no.22
Aurangabad
MAHARASHTRA 
9028050872

drketan.mgmmcha@gmail.com 
Dr P Radhika  MNJ Institute of Oncology and Regional Cancer Center  Department of medical oncology AC Gaurds roads Hydrabad 500004 Telangana India
Hyderabad
TELANGANA 
9848792682

radhika.parimkayala@gmail.com 
Dr Kshitij Joshi  MOC, Cancer Care& Research centre   Ville parle, Mumbai, Maharashtra, 400057
Mumbai
MAHARASHTRA 
9833662891

drkshitijjoshi@mocindia.co.in 
Dr Abhishek Anand  Narayana cancer center  Rd no. 0, Indrapuri, Keshri, Nagar, Patana, Bihar 800024
Patna
BIHAR 
8105502481

drabhishek2508@gmail.com 
Dr Meher Lakshmi Konatam  Nizam’s Institute of Medical Science  Ground floor RoomNo25 Punjgutta Hyderabad 500082 Telangana India
Hyderabad
TELANGANA 
9440592569

drmeherlak@gmail.com 
DrRushabh Kothari   Oncowin Cancer Center  Room no OPD 2 7th Floor HR Elanza Vikas Gruh Road Nr Mahalaxmi Five Roads Paldi Ahmedabad-380007
Ahmadabad
GUJARAT 
9167196692

rushabhkothari13@yahoo.com 
Dr Anshul Agarwal  PP Maniya Hospital Private LTD  OPD-5 1st floor Mamta Park Society-1 opp Dharuka College Kapodra Varachha Main Road Surat Gujarat- 395006 INDIA
Surat
GUJARAT 
8657068668

anshul.oncology@gmail.com 
Dr Sandeep Jasuja  R K Birla Cancer Center SMS Medical College  Jaipur 302004 Rajasthan India
Jaipur
RAJASTHAN 
9660121475

sandeepjasuja99@gmail.com 
Dr Lokesh K N   Radhakrishna Multispeciality Hospital And IVF Center  OPD no 6or 7 Ground Floor Radhakrishna Multispecialty Hospital & IVF Center 3-4 Sunrise Towers, 1st phase Girinagar Banashankari 3rd Stage Bengaluru Karnataka 560085
Bangalore
KARNATAKA 
8971609070

drlokeshkn.rmh@gmail.com 
Dr Kannan Jayaraman  Rajiv Gandhi Government General Hospital Madras Medical College  6th floor Tower 3 G H Post office Poonumalle High Road 3 Grand southern Tank Road Park Town Chennai 600 003.
Chennai
TAMIL NADU 
8921219255

drjkannan.research@gmail.com 
Dr Aditi Harsh Thanky   Rajkot Cancer Society  5th floor Nathalal Parekh Cancer Institute Near Hanuman Madhi Chowk 1 Tirupati Nagar Rajkot 360007 Gujarat India
Rajkot
GUJARAT 
9925025381

aditik2008@yahoo.com 
Dr Aniket Thoke  Sanjeevani CBCC USA Cancer Hospital  Unit I ground floor Department of Medical Oncology Sanjeevani CBCC USA Cancer Hospital Infront Jain Mandir Dawada Colony Pachpedi Naka Raipur 492001 India
Raipur
CHHATTISGARH 
9752929741

drthoke@gmail.com 
Dr Bhushan Tapiram Nemade   Sankalp Specialty Hospital  OPD room no 1 Ground floor Dhanvantari Marg Vallabh Nagar Behind Chhan Hotel Mumbai Agra Highway Mumbai Naka Nashik Maharashtra India- 422009
Nashik
MAHARASHTRA 
9766126162

drvknemade@yahoo.co.in 
Dr Surender Beniwal  Sarder Patel Medical College and Hospital  Sardar Patel Colony Bikaner Rajasthan 334001 India
Bikaner
RAJASTHAN 
9414370484

beniwal.surendra@gmail.com 
Dr Kausadikar Shripad Rameshrao  Seth Nandlal Dhoot Hospital  Ground floor A1 A2 MIDC Chikalthana Jalna road Near Airport Aurangabad Maharashtra India 431210
Aurangabad
MAHARASHTRA 
9909928993

drsrkausadikar.research@gmail.com 
Dr Viraj Lavangia   Shalby Hospital  9th Floor Clinical research department Opp Karnvati Club SG Highway Ahmedabad-380015 Gujarat India
Ahmadabad
GUJARAT 
9908711057

drvirajlavingia@gmail.com 
Dr Alpesh Kikani  Shashwat Haemato Onco Assocaites  2nd Floor CIGIS Hospital NrBalaji Hall 150 Feet Ring Road Rajkot 360004 Gujarat India
Rajkot
GUJARAT 
9601649096

alpesh.kikani@shashwat.one 
Dr Satheesh C T   Spandana Oncology Centre  Room no 1 consultant ground floor 919 New No 68 28th Main Road 9th block Jayanagar Bangalore-560068
Bangalore
KARNATAKA 
9242698750

drsatheeshct@gmail.com 
Dr Ghanshayam Biswas   Sparsh Hospital & Critical care Pvt. Ltd  Ground floor old building A/407 Saheed Nagar Khordha Bhubaneshwar Odisha-751007 India
Khordha
ORISSA 
9937500878

drgbiswas@gmail.com 
Dr Karthikeyan S  SRM Medical College Hospital and Research Center   SRM Nagar, Kattankulathur 603203, Chengalpattu district, TamilNadu, India.
Chennai
TAMIL NADU 
9964839602

drkarthikssmc@gmail.com 
Dr Sathiyamoorthy PN  Stanley Hospital and Medical College   Unnamed Road, seven wells north, old washermanpet, chennai
Chennai
TAMIL NADU 
9444221535

drpnsathiyamoorthy.research@gmail.com 
Dr Javvid Muzamil  Super speciality govt medical college  Department of oncology Ground floor Karan nagar Srinagar Jammu and Kashmir 190010
Srinagar
JAMMU & KASHMIR 
7006787372

javvidmd@gmail.com 
Dr Neha Gupta  Swami Harshankaranand Ji Hospital and Research Centre  Room no 9 Ground floor N 8 237 Newada BHU DLW Road Sunderpur Varnasi 221004 Uttar Pradesh India
Varanasi
UTTAR PRADESH 
8004354185

drneha_500@yahoo.com 
Dr Premkumar Devadoss  Tamil Nadu Government Multi Super Speciality Hospital  1st floor Depart of Clinical Research Omandurar Government Estate Opp the Hindu Mount Road Anna Salai Chennai Tamil Nadu 600002
Chennai
TAMIL NADU 
8792567193

drpremkumar.tngmssh@gmail.com 
Dr Rakesh Taran  Taran Onco Care  Ground floor 1 Ravindra Nagar Near Patrakar Square Indore MP 452018
Indore
MADHYA PRADESH 
9009779517

rakeshtaran@yahoo.com 
Dr Vanita Noronha   Tata Memorial Hospital  OPD 303 Homi Babha Building Dr Ernest Borges Rd Parel East Parel Mumbai Maharashtra 400012 India
Mumbai
MAHARASHTRA 
9769328047

vanita.noronha@gmail.com 
Dr Ankit Patel  Unique Hospital Multispeciality and Research Insititute  Ground floor OPD 1and 2 OPP Kiran Motors Nr Canal Civil Hospital Char Rasta Sosyo circle lane Off Ring Road Surat 395002
Surat
GUJARAT 
9825404202

dr.ankitoncologist@gmail.com 
Dr Kaushal Kalra  VMMC and safdarjung Hospital  New delhi-110029
New Delhi
DELHI 
9968663394

kaushalkalra@yahoo.com 
Dr Harish Kancharla   Yashoda Super Specialty Hospital  Raj Bhavan Road Somajiguda Hydrabad 500082 Telangana India
Hyderabad
TELANGANA 
9781812244

harik486@gmail.com 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 59  
Name of Committee  Approval Status 
Aurangabad healthcare and research LLP IEC  Submittted/Under Review 
Charnock Ethics Committee Charnock Hospital Pvt. Ltd.  Approved 
Ethics comittee for research on human subjects  Submittted/Under Review 
Ethics Comittee SMS Medical College and attached hospital  Submittted/Under Review 
Ethics Committee , S.P. Medical College  Submittted/Under Review 
Ethics Committee, Sanjeevani Cancer Hospital  Submittted/Under Review 
Ethics Committee, Unique Hospital  Submittted/Under Review 
Fortis Hospital Institutional Ethics Committee   Submittted/Under Review 
Good Society For Ethical Research  Submittted/Under Review 
HCG NCHRI cancer center Institutional ethics Committee   Submittted/Under Review 
Human Ethics Committee, Regional Cancer Center  Submittted/Under Review 
IEC Lifeline diagnostic center cum nursing homr  Submittted/Under Review 
Independent EC Namaste Integrated Services  Submittted/Under Review 
Institutional Ethics Comittee Acharya Harihar post graduate institute of cancer  Submittted/Under Review 
Institutional Ethics Comittee BGS  Approved 
Institutional Ethics Comittee for ESIC Faridabad  Submittted/Under Review 
Institutional ethics comittee KLE University  Submittted/Under Review 
Institutional Ethics Comittee MPMMCC  Submittted/Under Review 
Institutional Ethics Comittee-II TMC  Submittted/Under Review 
Institutional Ethics Committee Ethics Committee - Shalby Limited  Submittted/Under Review 
Institutional Ethics Committee IGIMS  Submittted/Under Review 
Institutional Ethics Committee Amrita Institute of Medical Sciences AIMS  Submittted/Under Review 
Institutional Ethics Committee BGS Institute  Approved 
Institutional Ethics Committee Chittaranjan National Cancer Institute  Submittted/Under Review 
Institutional Ethics Committee Government Stanley Medical College and Hospital  Submittted/Under Review 
Institutional Ethics Committee HCG Cancer Centre   Submittted/Under Review 
Institutional Ethics Committee Human, Gokul Lifecare Private Limited   Submittted/Under Review 
Institutional Ethics Committee Human, Gokul Life Care Pvt Ltd.  Submittted/Under Review 
Institutional Ethics Committee Kainos Super Speciality Hospital  Submittted/Under Review 
Institutional Ethics Committee Manavata Clinical Research  Submittted/Under Review 
Institutional Ethics Committee Spandana Oncology Centre   Approved 
Institutional Ethics Committee Sparsh Hospital and Critical Care Private limited   Submittted/Under Review 
Institutional Ethics Committee VMMC And SAFDARJUNG HOSPITAL  Submittted/Under Review 
Institutional Ethics Committee, Madras Medical College, Rajiv Gandhi Government Hospital  Submittted/Under Review 
Institutional Ethics Committee, AIIMS  Submittted/Under Review 
Institutional Ethics Committee, Ashwin Hospital Ashwin Hospital  Submittted/Under Review 
Institutional Ethics Committee, BSL Eye Care  Submittted/Under Review 
Institutional Ethics Committee, itcucurie city, cancer center  Submittted/Under Review 
Institutional Ethics Committee, KCHRC, Muni Seva Ashram  Submittted/Under Review 
Institutional Ethics Committee, Mahatama Gandhi Medical College and Hospital   Submittted/Under Review 
Institutional Ethics Committee, Meenakshi Mission Hospital and Research Centre  Submittted/Under Review 
Institutional Ethics Committee-TNGMSSH   Submittted/Under Review 
Institutional Ethics CommitteeSuper speciality govt medical college Karan nagar Srinagar  Submittted/Under Review 
Institutional Review Board Mahatama Gandhi Cancer Hospital,Research Institute  Submittted/Under Review 
Instiutional Ethics Committee,GKMC   Submittted/Under Review 
Kingsway Hospital Ethics Committee  Submittted/Under Review 
Kiran Hospital Ethics Committee (Kiran Hospital Multi Super Speciality Hospital and Research Center  Submittted/Under Review 
Lifepoint Research- Ethics Committee  Submittted/Under Review 
MNJ Institute of Oncology & Regional Cancer Center, Ethics Committee  Submittted/Under Review 
Mumbai Oncocare Centre IEC Cellcure-Cancer Centre Private Limited   Submittted/Under Review 
Navsanjeevani Hospital Ethics Committee  Approved 
NIMS Institutional Ethics Committee  Submittted/Under Review 
PP Maniya Hospital Ethics Committee PP Maniya Hospital Pvt Ltd   Submittted/Under Review 
Rectitude Ethics commitee, DNS Hospital  Submittted/Under Review 
Rectitude Ethics commitee, DNS Hospital Pvt. Ltd  Submittted/Under Review 
Sangani Hospital Ethics Committee  Submittted/Under Review 
SRM Medical College Hospital and Research Centre  Submittted/Under Review 
Swarnim Ethics Committee  Submittted/Under Review 
Yashoda Academy of Medical Education and Research   Submittted/Under Review 
 
Regulatory Clearance Status from DCGI  
Status 
Approved/Obtained 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C349||Malignant neoplasm of unspecifiedpart of bronchus or lung,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Innovators Nivolumab (Opdivo®/Opdyta®)  dose is 3 mg/kg every 14 days 30 - minute intravenous infusion for upto 12 cycles  
Intervention  Lupin Nivolumab (LUBT022)   dose is 3 mg/kg every 14 days 30 - minute intravenous infusion for upto 12 cycles  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  Male or female 18 years of age Patient with histologically or cytologically confirmed diagnosis Patients must have experienced disease recurrence or progression after one first line therapy Patients must have received at least 2 cycles of chemotherapy Patients who received adjuvant neoadjuvant or definitive chemoradiation therapy within 6 months Patients with recurrent disease greater than 6 months Presence of at least one measurable target lesion as per RECIST criteria version 1.1 ECOG performance status of 0 or 1 8 Screening laboratory values that meet the ANC Platelets Hemoglobin Serum bilirubin AST and ALT Serum creatinine creatinine clearance criteria as per protocol  
 
ExclusionCriteria 
Details  Patients with CNS metastases are eligible only if the metastases are adequately treated Patient with a condition requiring systemic treatment with either corticosteroids Patient with active known or suspected autoimmune disease All toxicities attributed to prior anti-cancer therapy Prior therapy with anti-tumor vaccines or other immuno-stimulatory antitumor agents Prior radiotherapy or radiosurgery received within 2 weeks prior to screening Patients with interstitial lung disease Prior therapy History of other primary malignancy Positive test result for HIV Hepatitis B Hepatitis C History of allergy or intolerance History of hypersensitivity reactions Major surgical procedure or significant traumatic injury within 28 days prior to screening Received any therapy Pregnant or lactating women & all men who not follow contraceptive measure  
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Participant, Investigator and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Overall Response Rate (ORR)   Overall Response Rate (ORR) at Baseline, Cycle 5, Cycle 9, EOS,
 
 
Secondary Outcome  
Outcome  TimePoints 
Efficacy:
• Disease control rate (DCR)
Safety:
• Incidence of TEAEs
Immunogenicity:
• Proportion of patients with binding and
neutralizing antibodies at the end of Cycle 4, 8,
and 12
Pharmacokinetics:
• Descriptive assessment of PK parameters in subgroup  
Efficacy:
• Disease control rate (DCR) at the end of Cycle 12
Safety:
• Incidence of TEAEs baseline to End of study till cycle 12
Immunogenicity:
• immunogenicity will be collected pre-dose at Cycle 1, at the end of Cycle 4 (pre-dose of Cycle 5), Cycle 8 (pre-dose of Cycle 9),
and at end of Cycle 12 (pre-dose of EOS)
• Descriptive assessment of PK parameters in subgroup at C1D1,C1D2,C1D3,C1D7, C4D1, C6D1, C8D1, C10D1,
C12D1 and at EOS 
 
Target Sample Size   Total Sample Size="202"
Sample Size from India="202" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   07/04/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The proposed study is a randomized, double blind, parallel arm clinical trial to compare the efficacy, safety, immunogenicity and pharmacokinetics in patients with previously treated locally advanced or metastatic non-small cell lung cancer (NSCLC) following exposure cycle 12 (24 weeks). This is a monotherapy. The trial will include a screening period (upto 4 weeks), and a double-blind treatment period. The eligible patient will be randomized and receive test or reference arm. Patient will be dosed on 3 mg/kg solution by intravenous (IV) route every 2 weeks till cycle 12 (week 24-last dose) or until disease progression or discontinued from the study due to any other reasons. Overall response rate will be assessed (radiological assessment) as per RECIST 1.1 criteria. PK parameters will be evaluated as Cmax, AUC, terminal phase half-life. 
Close